W James Alexander - Net Worth and Insider Trading

W James Alexander Net Worth

The estimated net worth of W James Alexander is at least $28,467 dollars as of 2024-11-10. W James Alexander is the SR. VP, Chief Medical Officer of BioCryst Pharmaceuticals Inc and owns about 3,659 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $28,467. Details can be seen in W James Alexander's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that W James Alexander has not made any transactions after 2007-07-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of W James Alexander

To

W James Alexander Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, W James Alexander owns 2 companies in total, including Soleno Therapeutics Inc (SLNO) , and BioCryst Pharmaceuticals Inc (BCRX) .

Click here to see the complete history of W James Alexander’s form 4 insider trades.

Insider Ownership Summary of W James Alexander

Ticker Comapny Transaction Date Type of Owner
SLNO Soleno Therapeutics Inc 2016-03-28 director
BCRX BioCryst Pharmaceuticals Inc 2007-07-31 SR. VP & Chief Medical Officer

W James Alexander Latest Holdings Summary

W James Alexander currently owns a total of 1 stock. W James Alexander owns 3,659 shares of BioCryst Pharmaceuticals Inc (BCRX) as of July 31, 2007, with a value of $28,467.

Latest Holdings of W James Alexander

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BCRX BioCryst Pharmaceuticals Inc 2007-07-31 3,659 7.78 28,467

Holding Weightings of W James Alexander


W James Alexander Form 4 Trading Tracker

According to the SEC Form 4 filings, W James Alexander has made a total of 0 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years. The most-recent trade in BioCryst Pharmaceuticals Inc is the acquisition of 2,374 shares on July 31, 2007, which cost W James Alexander around $16,737.

Insider Trading History of W James Alexander

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

W James Alexander Trading Performance

GuruFocus tracks the stock performance after each of W James Alexander's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by W James Alexander is 18.14%. GuruFocus also compares W James Alexander's trading performance to market benchmark return within the same time period. The performance of stocks bought by W James Alexander within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how W James Alexander's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of W James Alexander

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 25.36 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 22.82 LIMIT LIMIT LIMIT LIMIT LIMIT

W James Alexander Ownership Network

Ownership Network List of W James Alexander

No Data

Ownership Network Relation of W James Alexander

Insider Network Chart

W James Alexander Owned Company Details

What does Soleno Therapeutics Inc do?

Who are the key executives at Soleno Therapeutics Inc?

W James Alexander is the director of Soleno Therapeutics Inc. Other key executives at Soleno Therapeutics Inc include See Remarks Patricia C Hirano , See Remarks Kristen Yen , and director & See Remarks Bhatnagar Anish .

Soleno Therapeutics Inc (SLNO) Insider Trades Summary

Over the past 18 months, W James Alexander made no insider transaction in Soleno Therapeutics Inc (SLNO). Other recent insider transactions involving Soleno Therapeutics Inc (SLNO) include a net sale of 479,373 shares made by Bhatnagar Anish , a net sale of 79,014 shares made by Kristen Yen , and a net sale of 47,490 shares made by Patricia C Hirano .

In summary, during the past 3 months, insiders sold 1,210,871 shares of Soleno Therapeutics Inc (SLNO) in total and bought 0 shares, with a net sale of 1,210,871 shares. During the past 18 months, 2,825,824 shares of Soleno Therapeutics Inc (SLNO) were sold and 1,210,087 shares were bought by its insiders, resulting in a net sale of 1,615,737 shares.

Soleno Therapeutics Inc (SLNO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Soleno Therapeutics Inc Insider Transactions

No Available Data

W James Alexander Mailing Address

Above is the net worth, insider trading, and ownership report for W James Alexander. You might contact W James Alexander via mailing address: 307 Whiperwood Drive, Cary Nc 27511.